LSE - Delayed Quote • GBp
GSK plc (GSK.L)
At close: 4:35 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
6,768,000.00
6,768,000.00
7,403,000.00
7,952,000.00
8,441,000.00
Investing Cash Flow
-1,595,000.00
-1,595,000.00
-8,772,000.00
-1,777,000.00
2,161,000.00
Financing Cash Flow
-5,641,000.00
-5,641,000.00
823,000.00
-7,589,000.00
-10,132,000.00
End Cash Position
2,858,000.00
2,858,000.00
3,425,000.00
3,819,000.00
5,262,000.00
Capital Expenditure
-2,344,000.00
-2,344,000.00
-2,258,000.00
-2,654,000.00
-1,945,000.00
Issuance of Capital Stock
10,000.00
10,000.00
25,000.00
21,000.00
29,000.00
Issuance of Debt
223,000.00
223,000.00
2,046,000.00
301,000.00
3,298,000.00
Repayment of Debt
-2,593,000.00
-2,593,000.00
-6,668,000.00
-2,304,000.00
-7,332,000.00
Free Cash Flow
4,424,000.00
4,424,000.00
5,145,000.00
5,298,000.00
6,496,000.00
12/31/2020 - 7/1/1988
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AZN.L AstraZeneca PLC
11,352.00
+0.75%
SAN.PA Sanofi
87.70
-1.29%
NOVN.SW Novartis AG
89.12
+0.20%
ROG.SW Roche Holding AG
222.20
-3.27%
BAYN.DE Bayer Aktiengesellschaft
26.97
-1.37%
SNY Sanofi
46.56
-2.38%
AZN AstraZeneca PLC
71.20
+0.49%
NVS Novartis AG
98.38
+1.13%
GILD Gilead Sciences, Inc.
67.07
+0.05%
GRF.MC Grifols, S.A.
8.38
-3.26%